Search results
3 lis 2022 · The Z line in the esophagus is the term for a faint zig-zag impression at the gastro-esophageal junction that demarcates the transition between the stratified squamous epithelium in the esophagus and the intestinal epithelium of the gastric cardia (the squamocolumnar junction).
- Edit Article
Updating… Please wait. Unable to process the form. Check for...
- Photo 1: Gastroesophageal Squamocolumnar Junction
This image shows the normal abrupt demarcation between the...
- Case 1a
2; 3; 4; Continue > Next Case > Case courtesy of Matt A....
- Edit Article
8 sie 2023 · The squamocolumnar junction, also referred as Z-line, is the area where the squamous epithelial lining of the esophagus (pale pink colored) meets the columnar lining mucosa of the stomach (salmon-colored).
There is no accepted classification system for the endoscopic description of the squamocolumnar mucosal junction, the so-called “Z-line.” Furthermore, no clear definition of the normal Z-line exists. A classification of the Z-line appearance has been proposed: the ZAP classification.
23 mar 2023 · Question 4. Why is it important to correctly identify diaphragmatic hiatus and esophagogastric and squamous-columnar junctions at upper GI endoscopy? Answer: At endoscopy, the diaphragmatic hiatus can be seen as a concentric narrowing of the lumen related to the diaphragmatic contraction during inspiration.
Barrett's esophagus (BE) is a common condition associated with chronic gastroesophageal reflux disease. BE is the only known precursor to esophageal adenocarcinoma, a highly lethal cancer with an increasing incidence over the last 5 decades.
27 sie 2019 · Since gastroesophageal reflux is known to be of etiological importance in both Barrett's esophagus and esophageal adenocarcinoma, we aimed to study which endoscopic alterations at the Z-line can be attributed to a previous history of reflux symptoms.
18 kwi 2018 · For the diagnosis of Barrett’s esophagus, there is an emerging consensus among guidelines not to biopsy an irregular Z line in the absence of a visible abnormality due to the low risk of progression to esophageal adenocarcinoma in these patients.
